Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.
about
Clinical Predictive Factors in Diabetic Kidney Disease ProgressionPlasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitusDiabetes mellitus: The epidemic of the century.Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.Systemic and renal lipids in kidney disease development and progression.Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.Associations of TNFR1 with kidney function outcomes by age, gender, and baseline kidney function status: Data from the Heart and Soul Study.Renal biopsy-driven molecular target identification in glomerular disease.Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.Immune modulation by curcumin: The role of interleukin-10.Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis.White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in Type 2 diabetes.Inhibition of tumor necrosis factor signaling attenuates renal immune cell infiltration in experimental membranous nephropathy.Association of TNF Receptor 2 and CRP with GFR Decline in the General Nondiabetic Population.Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease.High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease.Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes
P2860
Q26749494-1716A66B-26CB-4B2C-9906-F453778927E3Q33897901-06DA5EDC-B18E-4AC9-9D98-8D8C8ECEA4B7Q34671155-7C8E55EE-EFCD-498F-91DC-9164D09FDC06Q35630730-67767D29-74BF-49BF-ADF9-33B73072BB04Q36629282-6AC531CA-3DEE-4AEF-BEF9-F13E0A87BB23Q36723318-56E0DC82-47C6-485B-A405-FD82AB54D97AQ36770851-D1154F22-8598-498E-B773-E6F3D6035332Q37148885-73A9D091-F949-434D-B662-AE555B7FECB1Q37217446-42047507-055E-4B5C-87A2-5E166DDBCDE5Q38553932-193A0780-D284-440C-BB09-9243231C2E8FQ38613155-7ED29E03-24A3-4DC9-9084-6A4159C3D900Q38701041-62C72C16-F8FB-45F5-A27B-FA7877F37C0DQ38709338-C6299DF8-EB0C-4B9E-9F80-F4C97F63176AQ38732291-76ECE2DE-09D6-4F6C-8836-317796790256Q38862190-6410929E-8D0E-456F-9796-97DEF02BDCE0Q39286825-15BDBEBF-56C2-4545-A285-DEC2F8A73EE5Q40097338-715DE5EC-9576-4225-9861-7E6F6AF71A1DQ41809955-B3746B60-1860-4018-A662-CA2C68EC28B9Q46765226-68A185E8-86DC-44F9-9F9C-10C9E7BC0C43Q49177794-2CB4EAF8-1F41-424F-92D2-90E31B540B62Q51155704-EFB498C0-1F8C-4523-B8AC-8B3888B84416Q52568967-7B8A3097-7290-4C18-AE7B-A5A942860A3BQ52630076-AE3E5F14-974B-4BB5-BD1E-5DA86E4705C4Q53142026-0289E29F-8BF4-4D5E-B12C-AFD4F97577F7Q55312504-61FCB46A-41A0-4FE2-8D54-165A1E1F5D88Q58548990-4C85521D-D421-43F0-9AD0-FF954BD4C440
P2860
Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Elevation of circulating TNF r ...... Indians with type 2 diabetes.
@ast
Elevation of circulating TNF r ...... Indians with type 2 diabetes.
@en
type
label
Elevation of circulating TNF r ...... Indians with type 2 diabetes.
@ast
Elevation of circulating TNF r ...... Indians with type 2 diabetes.
@en
prefLabel
Elevation of circulating TNF r ...... Indians with type 2 diabetes.
@ast
Elevation of circulating TNF r ...... Indians with type 2 diabetes.
@en
P2093
P2860
P356
P1433
P1476
Elevation of circulating TNF r ...... n Indians with type 2 diabetes
@en
P2093
Andrzej S Krolewski
Meda E Pavkov
Monika A Niewczas
Robert G Nelson
P2860
P2888
P304
P356
10.1038/KI.2014.330
P407
P577
2014-10-01T00:00:00Z